PB1762: ponatinib versus imatinib with reduced-intensity chemotherapy in patients with newly diagnosed philadelphia chromosome–positive (ph+) acute lymphoblastic leukemia (all): ph...

por Jabbour, E., Martinelli, G., Vignetti, M., Kantarjian, Hagop M., Gómez Almaguer, David, Minami, Y., Dombret, H., Hennessy, M., Vorog, A., Wang, B., Ribera, J. M.
Publicado 2022

Combining Anti-Mir-155 with Chemotherapy for the Treatment of Lung Cancers

por Van Roosbroeck, Katrien, Fanini, Francesca, Setoyama, Tetsuro, Ivan, Cristina, Rodríguez Aguayo, Cristian, Fuentes Mattei, Enrique, Xiao, Lianchun, Vannini, Ivan, Redis, Roxana S., D'Abundo, Lucilla, Zhang, Xinna, Nicoloso, Milena S., Rossi, Simona, González Villasana, Vianey, Rupaimoole, Rajesha, Ferracin, Manuela, Morabito, Fortunato, Neri, Antonino, Ruvolo, Peter P., Ruvolo, Vivian R., Pecot, Chad V., Amadori, Dino, Abruzzo, Lynne V., Calin, Steliana, Wang, Xuemei, You, M. James, Ferrajoli, Alessandra, Orlowski, Robert, Plunkett, William, Lichtenberg, Tara M., Davuluri, Ramana V., Berindan Neagoe, Ioana, Negrini, Massimo, Wistuba, Ignacio I., Kantarjian, Hagop M., Sood, Anil K., Lopez Berestein, Gabriel, Keating, Michael J., Fabbri, L. Muller, Calin, George A.
Publicado 2016